News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,047 Results
Type
Article (76461)
Company Profile (649)
Press Release (751936)
Multimedia
Podcasts (143)
Webinars (19)
Section
Business (229136)
Career Advice (3785)
Deals (39409)
Drug Delivery (129)
Drug Development (89796)
Employer Resources (198)
FDA (17996)
Job Trends (17201)
News (390298)
Policy (39018)
Tag
Academia (3001)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56447)
ALS (119)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (188)
Approvals (17948)
Artificial intelligence (373)
Autoimmune disease (36)
Automation (19)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (443)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (390)
Cancer (3085)
Cardiovascular disease (249)
Career advice (3227)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (572)
Cervical cancer (24)
Clinical research (73331)
Collaboration (1111)
Company closure (3)
Compensation (711)
Complete response letters (34)
COVID-19 (2904)
CRISPR (67)
C-suite (358)
Cystic fibrosis (121)
Data (3089)
Decentralized trials (2)
Denatured (50)
Depression (76)
Diabetes (378)
Diagnostics (6974)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (163)
Drug pricing (151)
Drug shortages (36)
Duchenne muscular dystrophy (135)
Earnings (95532)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (130673)
Executive appointments (909)
FDA (19737)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1010)
Gene editing (147)
Generative AI (35)
Gene therapy (438)
GLP-1 (935)
Government (5233)
Grass and pollen (6)
Guidances (181)
Healthcare (20903)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (11)
Indications (40)
Infectious disease (3100)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (125)
Interviews (742)
IPO (17838)
IRA (55)
Job creations (5031)
Job search strategy (2632)
Kidney cancer (14)
Labor market (56)
Layoffs (590)
Leadership (26)
Legal (9976)
Liver cancer (85)
Longevity (12)
Lung cancer (432)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (439)
MASH (99)
Medical device (14714)
Medtech (14719)
Mergers & acquisitions (22300)
Metabolic disorders (965)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (141)
Neuropsychiatric disorders (42)
Neuroscience (2324)
NextGen: Class of 2025 (7644)
Non-profit (5090)
Now hiring (48)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (125)
Parkinson's disease (199)
Partnered (23)
Patents (320)
Patient recruitment (173)
Peanut (55)
People (64850)
Pharmaceutical (134)
Pharmacy benefit managers (25)
Phase I (22658)
Phase II (31963)
Phase III (24093)
Pipeline (1703)
Policy (243)
Postmarket research (3297)
Preclinical (10067)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (527)
Real estate (7209)
Recruiting (76)
Regulatory (26567)
Reports (61)
Research institute (2662)
Resumes & cover letters (590)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (27)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4224)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (91)
Vaccines (916)
Venture capital (58)
Weight loss (332)
Women's health (51)
Worklife (20)
Date
Today (105)
Last 7 days (399)
Last 30 days (1997)
Last 365 days (33505)
2025 (18181)
2024 (37926)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57665)
2019 (51316)
2018 (39099)
2017 (36903)
2016 (37861)
2015 (43886)
2014 (38728)
2013 (34870)
2012 (36730)
2011 (36815)
2010 (36487)
Location
Africa (1206)
Alabama (70)
Alaska (7)
Arizona (263)
Arkansas (14)
Asia (49310)
Australia (8470)
California (7795)
Canada (2416)
China (727)
Colorado (340)
Connecticut (346)
Delaware (203)
Europe (111727)
Florida (1158)
Georgia (264)
Hawaii (2)
Idaho (65)
Illinois (729)
India (32)
Indiana (386)
Iowa (18)
Japan (239)
Kansas (115)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1105)
Massachusetts (5960)
Michigan (273)
Minnesota (484)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2192)
New Mexico (31)
New York (2185)
North Carolina (1239)
North Dakota (10)
Northern California (3363)
Ohio (252)
Oklahoma (17)
Oregon (46)
Pennsylvania (1661)
Puerto Rico (18)
Rhode Island (39)
South America (1579)
South Carolina (36)
South Dakota (1)
Southern California (2887)
Tennessee (129)
Texas (1188)
United States (29372)
Utah (231)
Virginia (212)
Washington D.C. (80)
Washington State (685)
West Virginia (4)
Wisconsin (84)
829,047 Results for "atom bioscience and pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Atom Bioscience Marks Gout Awareness Day with Video Detailing Risks of Hyperuricemia, the Cause of Gout
Atom Bioscience, a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such as gout, is calling for increased understanding of the dangers of chronic gout to help mark Gout Awareness Day, May 22, 2024.
May 21, 2024
·
2 min read
Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today the first patient has been dosed in a Phase 2b/3
October 9, 2023
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Press Releases
Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depression (TRD) in Taiwan
June 23, 2025
·
2 min read
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Press Releases
Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate the Public on Risk Factors and Treatment Options for This Growing Disease
May 22, 2025
·
2 min read
Drug Development
Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout
Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, has begun enrolling patients in the US for in a Phase 2b/3 clinical trial of ABP-671, a novel investigational orally administered URAT1 inhibitor, for the treatment of chronic gout.
April 24, 2024
·
2 min read
Press Releases
Drug Farm and Xiamen Amoytop Biotech Co., Ltd. Enter into Option Agreement for First-In-Class Innate Immunity Agonist, DF-006 to Treat Hepatitis B and Hepatocellular Cancer
May 28, 2025
·
3 min read
1 of 82,905
Next
